The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
Abbott | Common | 002824100 | 18,400,804 | 167,600 | SH | SOLE | 167,600 | 0 | 0 | ||
Abbvie | Common | 00287Y109 | 32,726,025 | 202,500 | SH | SOLE | 202,500 | 0 | 0 | ||
Allstate | Common | 020002101 | 24,177,480 | 178,300 | SH | SOLE | 178,300 | 0 | 0 | ||
Uhaul | Common | 023586100 | 4,517,560 | 75,055 | SH | SOLE | 75,055 | 0 | 0 | ||
Uhaul B | Common | 023586506 | 36,315,939 | 660,530 | SH | SOLE | 660,530 | 0 | 0 | ||
Apple | Common | 037833100 | 8,380,485 | 64,500 | SH | SOLE | 64,500 | 0 | 0 | ||
Ashland | Common | 044209104 | 1,612,950 | 15,000 | SH | SOLE | 15,000 | 0 | 0 | ||
Avista | Common | 05379B107 | 9,089,700 | 205,000 | SH | SOLE | 205,000 | 0 | 0 | ||
Amryt | Common | 03217L106 | 2,300,829 | 315,182 | SH | SOLE | 315,182 | 0 | 0 | ||
CMS Energy | Common | 125896100 | 26,503,605 | 418,500 | SH | SOLE | 418,500 | 0 | 0 | ||
Acorda Theraputics | Cv 6.0% | 00484MAB2 | 3,750,000 | 5,000,000 | PRN | SOLE | 5,000,000 | 0 | 0 | ||
Accelerate Diagnostic | Cv 2.5% | 00430HAB8 | 2,760,000 | 3,000,000 | PRN | SOLE | 3,000,000 | 0 | 0 | ||
Duke Energy | Common | 26441C204 | 26,900,988 | 261,200 | SH | SOLE | 261,200 | 0 | 0 | ||
EDAP | Common | 268311107 | 6,029,850 | 565,652 | SH | SOLE | 565,652 | 0 | 0 | ||
Fate Theraputics | Common | 31189P102 | 575,130 | 57,000 | SH | SOLE | 57,000 | 0 | 0 | ||
AT & T | Common | 00206R102 | 20,840,120 | 1,132,000 | SH | SOLE | 1,132,000 | 0 | 0 | ||
Warner Bros. Discovery | Common | 934423104 | 137,555 | 14,510 | SH | SOLE | 14,510 | 0 | 0 | ||
Nextera Energy | Common | 302571104 | 29,051,000 | 347,500 | SH | SOLE | 347,500 | 0 | 0 | ||
Novavax | Cv 3.75% | 670002AB0 | 590,000 | 600,000 | PRN | SOLE | 600,000 | 0 | 0 | ||
Personalis | Common | 71535D106 | 99,000 | 50,000 | SH | SOLE | 50,000 | 0 | 0 | ||
908 Devices | Common | 65443P102 | 520,339 | 68,286 | SH | SOLE | 68,286 | 0 | 0 | ||
Lava Theraputics | Common | N51517105 | 350,000 | 100,000 | SH | SOLE | 100,000 | 0 | 0 | ||
Newmont | Common | 651639106 | 3,068,000 | 65,000 | SH | SOLE | 65,000 | 0 | 0 | ||
IGM Bioscience | Common | 449585108 | 935,550 | 55,000 | SH | SOLE | 55,000 | 0 | 0 | ||
Insteel | Common | 45774W108 | 7,540,480 | 274,000 | SH | SOLE | 274,000 | 0 | 0 | ||
Organon | Common | 68622V106 | 878,957 | 31,470 | SH | SOLE | 31,470 | 0 | 0 | ||
Mannkind | Common | 56400P706 | 1,028,035 | 195,073 | SH | SOLE | 195,073 | 0 | 0 | ||
Merck | Common | 589331107 | 33,584,565 | 302,700 | SH | SOLE | 302,700 | 0 | 0 | ||
Paratek | Cv 4.75% | 699374AA2 | 14,442,000 | 16,600,000 | PRN | SOLE | 16,600,000 | 0 | 0 | ||
Paratek | Common | 699374302 | 2,912,173 | 1,557,312 | SH | SOLE | 1,557,312 | 0 | 0 | ||
Pfizer | Common | 717081103 | 27,807,948 | 542,700 | SH | SOLE | 542,700 | 0 | 0 | ||
RLI | Common | 749607107 | 315,048 | 2,400 | SH | SOLE | 2,400 | 0 | 0 | ||
Supernus | Common | 868459108 | 3,285,385 | 92,105 | SH | SOLE | 92,105 | 0 | 0 | ||
Viatris | Common | 92556V106 | 670,827 | 60,272 | SH | SOLE | 60,272 | 0 | 0 | ||
Bausch Health | Common | 91911K102 | 5,846,680 | 931,000 | SH | SOLE | 931,000 | 0 | 0 | ||
XM Sirius | Common | 82968B103 | 3,841,803 | 657,843 | SH | SOLE | 657,843 | 0 | 0 | ||
XEL Energy | Common | 98389B100 | 26,115,975 | 372,500 | SH | SOLE | 372,500 | 0 | 0 |